[Experience with turbulent magnetic field as a component of breast cancer therapy].
Abstract
No adverse side-effects were reported in an investigation of the antitumor effect of turbulent magnetic field (TMF) carried out as a component of preoperative chemoradiotherapy for breast cancer at the Center's Clinic. The study group included 114 patients with locally advanced tumors(T3, N1-N3, M0). According to the clinical, roentgenological and histological evidence on the end-results, the procedure was highly effective. Also, it was followed by shorter and less extensive postoperative lymphorrhea.
AI evidence extraction
Main findings
In 114 patients with locally advanced breast cancer, turbulent magnetic field (TMF) used as a component of preoperative chemoradiotherapy was reported as highly effective based on clinical, roentgenological, and histological end-results. No adverse side-effects were reported, and postoperative lymphorrhea was described as shorter and less extensive.
Outcomes measured
- Antitumor effect / treatment effectiveness (clinical
- roentgenological
- histological end-results)
- Adverse side-effects
- Postoperative lymphorrhea duration and extent
Limitations
- Randomization not described in the abstract despite the publication type listing 'Clinical Trial'
- No exposure parameters reported (e.g.
- field strength
- frequency
- duration)
- No comparator/control group described
- Outcomes are described qualitatively without effect sizes or statistical details
View raw extracted JSON
{
"study_type": "randomized_trial",
"exposure": {
"band": null,
"source": "turbulent magnetic field (TMF) as component of preoperative chemoradiotherapy",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Patients with locally advanced breast cancer (T3, N1–N3, M0) receiving preoperative chemoradiotherapy",
"sample_size": 114,
"outcomes": [
"Antitumor effect / treatment effectiveness (clinical, roentgenological, histological end-results)",
"Adverse side-effects",
"Postoperative lymphorrhea duration and extent"
],
"main_findings": "In 114 patients with locally advanced breast cancer, turbulent magnetic field (TMF) used as a component of preoperative chemoradiotherapy was reported as highly effective based on clinical, roentgenological, and histological end-results. No adverse side-effects were reported, and postoperative lymphorrhea was described as shorter and less extensive.",
"effect_direction": "benefit",
"limitations": [
"Randomization not described in the abstract despite the publication type listing 'Clinical Trial'",
"No exposure parameters reported (e.g., field strength, frequency, duration)",
"No comparator/control group described",
"Outcomes are described qualitatively without effect sizes or statistical details"
],
"evidence_strength": "low",
"confidence": 0.66,
"peer_reviewed_likely": "yes",
"keywords": [
"turbulent magnetic field",
"TMF",
"breast cancer",
"preoperative chemoradiotherapy",
"clinical trial",
"lymphorrhea"
],
"suggested_hubs": []
}AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.
NNEMF synthesis
Synthesis pending.